Merck MRK
NYSE MRK
$145.93 +0.74 (+0.51%)
As of: Oct 16, 2026 · 3:59 PM EDT

Merck (MRK) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Merck (MRK) reported Liabilities and Shareholders Equity of $129.8 billion for Q2 2026, up 10.4% from $117.52 billion a year earlier and up 0.9% from the prior quarter.

Analysis

Merck (MRK) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Merck posted Liabilities and Shareholders Equity of $136.87 billion, up 16.9% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $117.11 billion in FY2024 (+9.8%), $106.68 billion in FY2023 (-2.3%), $109.16 billion in FY2022 (+3.3%) and $105.69 billion in FY2021 (+15.4%).
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $93.49 billion in Q3 2021 and a high of $136.87 billion in Q4 2025.
  • Year over year, Liabilities and Shareholders Equity has now increased in each of the last nine quarters, with growth averaging 10.3% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q2 2022 (growth of 18.1%); the low point was Q2 2023 (a decline of 2.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $128.69 billion (Q1 2026), $136.87 billion (Q4 2025) and $129.55 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 201.06 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 135.12 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 115.83 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 49.36 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 201.13 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 27.42 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 129.80 Bn
Mar 31, 2026 128.69 Bn
Dec 31, 2025 136.87 Bn
Sep 30, 2025 129.55 Bn
Jun 30, 2025 117.52 Bn
Mar 31, 2025 115.12 Bn
Dec 31, 2024 117.11 Bn
Sep 30, 2024 117.53 Bn
Jun 30, 2024 112.63 Bn
Mar 31, 2024 105.85 Bn
Dec 31, 2023 106.68 Bn
Sep 30, 2023 106.73 Bn
Jun 30, 2023 104.47 Bn
Mar 31, 2023 107.80 Bn
Dec 31, 2022 109.16 Bn
Sep 30, 2022 107.08 Bn
Jun 30, 2022 107.10 Bn
Mar 31, 2022 106.67 Bn
Dec 31, 2021 105.69 Bn
Sep 30, 2021 93.49 Bn
API Access

Merck Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MRK&period=max&api_key=YOUR_API_KEY